1. Design, Synthesis and Characterization of Novel Ni(II) and Cu(II) Complexes as Antivirus Drug Candidates against SARS-CoV-2 and HIV Virus. Aprajita and M. Choudhary. Journal of Molecular Structure, 2022. 1263: 133114. PMID[35465175]. PMCID[PMC9017811].
[PubMed]. HIV_04_2022.
2. Physicochemical Characterization of the Recombinant Lectin Scytovirin and Microbicidal Activity of the SD1 Domain Produced in Rice against HIV-1. Armario-Najera, V., A. Blanco-Perera, S.R. Shenoy, Y. Sun, S. Marfil, J. Muñoz-Basagoiti, D. Perez-Zsolt, J. Blanco, N. Izquierdo-Useros, T. Capell, B.R. O'Keefe, and P. Christou. Plant Cell Reports, 2022. 41(4): p. 1013-1023. PMID[35178612]. PMCID[PMC9034974].
[PubMed]. HIV_04_2022.
3. Beta-Catenin Regulates HIV Latency and Modulates HIV Reactivation. Barbian, H.J., M.S. Seaton, S.D. Narasipura, J. Wallace, R. Rajan, B. Sha, and L. Al-Harthi. Plos Pathogens, 2022. 18(3): e1010354. PMID[35255110]. PMCID[PMC8939789].
[PubMed]. HIV_04_2022.
4. HIV-1-RT Inhibition Activity of Satureja spicigera (C.KOCH) BOISS. Aqueous Extract and Docking Studies of Phenolic Compounds Identified by RP-HPLC-DAD. Bektaş, E., H. Sahin, A.O. Beldüz, and H. Güler. Journal of Food Biochemistry, 2022. 46(4): e13921. PMID[34477237].
[PubMed]. HIV_04_2022.
5. Altered Response Pattern Following AZD5582 Treatment of SIV-infected, ART-suppressed Rhesus Macaque Infants. Bricker, K.M., V. Obregon-Perko, B. Williams, D. Oliver, F. Uddin, M. Neja, L. Hopkins, A. Dashti, S. Jean, J.S. Wood, S. Ehnert, S. Liang, T. Vanderford, G.K. Tharp, S.E. Bosinger, A.P. Schauer, M. Mavigner, M.L. Cottrell, D. Margolis, R.M. Dunham, and A. Chahroudi. Journal of Virology, 2022. 96(7): e0169921. PMID[35293766].
[PubMed]. HIV_04_2022.
6. Combined Noncanonical NF-kB Agonism and Targeted BET Bromodomain Inhibition Reverse HIV Latency Ex Vivo. Falcinelli, S.D., J.J. Peterson, A.W. Turner, D. Irlbeck, J. Read, S.L. Raines, K.S. James, C. Sutton, A. Sanchez, A. Emery, G. Sampey, R. Ferris, B. Allard, S. Ghofrani, J.L. Kirchherr, C. Baker, J.D. Kuruc, C.L. Gay, L.I. James, G. Wu, P. Zuck, I. Rioja, R.C. Furze, R.K. Prinjha, B.J. Howell, R. Swanstrom, E.P. Browne, B.D. Strahl, R.M. Dunham, N.M. Archin, and D.M. Margolis. Journal of Clinical Investigation, 2022. 132(8): e157281. PMID[35426377]. PMCID[PMC9012286].
[PubMed]. HIV_04_2022.
7. Dimerization of the Peptide CXCR4-antagonist on Macromolecular and Supramolecular Protraction Arms Affords Increased Potency and Enhanced Plasma Stability. Harms, M., R.F. Hansson, S. Carmali, Y. Almeida-Hernández, E. Sanchez-Garcia, J. Münch, and A.N. Zelikin. Bioconjugate Chemistry, 2022. 33(4): p. 594-607. PMID[35293739].
[PubMed]. HIV_04_2022.
8. Impact of Integrase Sequences from HIV-1 Subtypes A6/A1 on the in Vitro Potency of Cabotegravir or Rilpivirine. Jeffrey, J.L., M. St Clair, P. Wang, C.F. Wang, Z.F. Li, J. Beloor, C. Talarico, R. Fridell, M. Krystal, C.T. White, S. Griffith, R. D'Amico, K. Smith, V. Van Eygen, J. Vingerhoets, K. Vandermeulen, W. Spreen, and J. van Lunzen. Antimicrobial Agents and Chemotherapy, 2022. 66(3): e0170221. PMID[34978890]. PMCID[PMC8923183].
[PubMed]. HIV_04_2022.
9. Pocket-to-lead: Structure-based de Novo Design of Novel Non-peptidic HIV-1 Protease Inhibitors Using the Ligand Binding Pocket as a Template. Kojima, E., A. Iimuro, M. Nakajima, H. Kinuta, N. Asada, Y. Sako, Z. Nakata, K. Uemura, S. Arita, S. Miki, C. Wakasa-Morimoto, and Y. Tachibana. Journal of Medicinal Chemistry, 2022. 65(8): p. 6157-6170. PMID[35416651].
[PubMed]. HIV_04_2022.
10. Antithetic Effect of Interferon-α on Cell-free and Cell-to-Cell HIV-1 Infection. R., S. Iwanami, K.B. Mar, Y. Kakizoe, N. Misawa, S. Nakaoka, Y. Koyanagi, A.S. Perelson, J.W. Schoggins, S. Iwami, and K. Sato. Plos Computational Biology, 2022. 18(4): e1010053. PMID[35468127]. PMCID[PMC9037950].
[PubMed]. HIV_04_2022.
11. Structure-based Design and Synthesis of Copper(II) Complexes as Antivirus Drug Candidates Targeting SARS-CoV-2 and HIV. Kumar, S. and M. Choudhary. New Journal of Chemistry, 2022. 46(15): p. 7128-7143. ISI[000772926200001].
[WOS]. HIV_04_2022.
12. CTNNBL1 Restricts HIV-1 Replication by Suppressing Viral DNA Integration into the Cell Genome. Liang, G.X., Y. He, L. Zhao, J.Y. Ouyang, W.Q. Geng, X.W. Zhang, X.X. Han, Y.J. Jiang, H.B. Ding, Y. Xiong, J.X. Dong, M. Liu, and H. Shang. Cell Reports, 2022. 38(11): 110533. PMID[35294870].
[PubMed]. HIV_04_2022.
13. Cytotoxicity and Antiviral Properties of Alkaloids Isolated from Pancratium maritimum. Masi, M., R. Di Lecce, N. Mérindol, M.P. Girard, L. Berthoux, I. Desgagné-Penix, V. Calabrò, and A. Evidente. Toxins, 2022. 14(4): 262. PMID[35448871]. PMCID[PMC9029599].
[PubMed]. HIV_04_2022.
14. Novel Compound Inhibitors of HIV-1(NL4-3) Vpu. Robinson, C.A., T.D. Lyddon, H.M. Gil, D.T. Evans, Y.V. Kuzmichev, J. Richard, A. Finzi, S. Welbourn, L. Rasmussen, N.M. Nebane, V.V. Gupta, S. Ananthan, Z. Cai, E.R. Wonderlich, C.E. Augelli-Szafran, R. Bostwick, R.G. Ptak, S.M. Schader, and M.C. Johnson. Viruses, 2022. 14(4): 817. PMID[35458546]. PMCID[PMC9024541].
[PubMed]. HIV_04_2022.
15. Estradiol Inhibits HIV-1(BaL) Infection and Induces CFL1 Expression in Peripheral Blood Mononuclear Cells and Endocervical Mucosa. Verma, N., S. Mukhopadhyay, P. Barnable, M.G. Plagianos, and N. Teleshova. Scientific Reports, 2022. 12(1): 6165. PMID[35418661]. PMCID[PMC9008051].
[PubMed]. HIV_04_2022.
16. Human Immunodeficiency Virus-1 Latency Reversal via the Induction of Early Growth Response Protein 1 to Bypass Protein Kinase C Agonist-associated Immune Activation. Wong, L.M., D.J. Li, Y.Y. Tang, G. Mendez-Lagares, G.R. Thompson, D.J. Hartigan-O'Connor, S. Dandekar, and G.C. Jiang. Frontiers in Microbiology, 2022. 13: 836831. PMID[35359743]. PMCID[PMC8960990].
[PubMed]. HIV_04_2022.
17. Heparanase Blockade as a Novel Dual-targeting Therapy for Covid-19. Xiang, J., M. Lu, M. Shi, X. Cheng, K.A. Kwakwa, J.L. Davis, X. Su, S.J. Bakewell, Y. Zhang, F. Fontana, Y. Xu, D.J. Veis, J.F. DiPersio, L. Ratner, R.D. Sanderson, A. Noseda, S. Mollah, J. Li, and K.N. Weilbaecher. Journal of Virology, 2022. 96(7): e0005722. PMID[35319225]. PMCID[PMC9006938].
[PubMed]. HIV_04_2022.
Patent Citations
18. Preparation of Bridged Tricyclic carbamoylpyridones Useful in Treatment and Prevention of HIV Infection. Chu, H., H. Guo, L. Jiang, J. Li, D.W. Lin, H.-J. Pyun, Q. Wu, H. Yang, A.D. Zajdlik, and J.R. Zhang. Patent. 2022. 2021-US52683 2022072520: 199pp.
[Patent]. HIV_04_2022.